Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Loss of BRCA2 Correlates with Reduced Long-term Survival of Sporadic Breast Cancer Patients

J.A. HAMPL, M. HAMPL, G. REIß, R. KOCH, H.-D. SAEGER and H.K. SCHACKERT
Anticancer Research January 2004, 24 (1) 281-290;
J.A. HAMPL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. HAMPL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. REIß
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. KOCH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.-D. SAEGER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.K. SCHACKERT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 24 no. 1 281-290

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 4, 2003
  • Accepted October 14, 2003
  • Published online January 1, 2004.

Copyright & Usage 
Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. J.A. HAMPL1,*,
  2. M. HAMPL2,*,
  3. G. REIß3,
  4. R. KOCH4,
  5. H.-D. SAEGER5 and
  6. H.K. SCHACKERT6
  1. 1Department of Neurosurgery, University of Cologne, 50931 Cologne
  2. 2Department of Obstetrics and Gynecology, Heinrich Heine University of Düsseldorf, 40225 Düsseldorf
  3. 3Department of Neurosurgery, Technical University of Dresden , 01307 Dresden, Germany
  4. 4Institute for Medical Informatics and Biometrics, Technical University of Dresden,01307 Dresden, Germany
  5. 5Department of General/Thoracic and Vascular Surgery, Technical University of Dresden, 01307 Dresden, Germany
  6. 6Department of Surgical Research, Technical University of Dresden, 01307 Dresden, Germany
  1. Correspondence to: J.A. Hampl, M.D., Department of Neurosurgery, University of Cologne, Joseph-Stelzmannstr. 9, 50931 Cologne, Germany. Tel: ++-49-221-478 4577, Fax: ++-49-221-478 7993, email: juergen.hampl{at}medizin.uni-koeln.de

Statistics from Altmetric.com

Cited By...

  • 186 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 24 (1)
Anticancer Research
Vol. 24, Issue 1
January-February 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Loss of BRCA2 Correlates with Reduced Long-term Survival of Sporadic Breast Cancer Patients
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 15 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Loss of BRCA2 Correlates with Reduced Long-term Survival of Sporadic Breast Cancer Patients
J.A. HAMPL, M. HAMPL, G. REIß, R. KOCH, H.-D. SAEGER, H.K. SCHACKERT
Anticancer Research Jan 2004, 24 (1) 281-290;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Loss of BRCA2 Correlates with Reduced Long-term Survival of Sporadic Breast Cancer Patients
J.A. HAMPL, M. HAMPL, G. REIß, R. KOCH, H.-D. SAEGER, H.K. SCHACKERT
Anticancer Research Jan 2004, 24 (1) 281-290;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
  • Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study
  • Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire